By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Voyager Therapeutics 

75 Sidney Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 910-509-3977 Fax: n/a



Company News
Voyager Therapeutics (VYGR) Announces Publication From The California Institute of Technology Of A Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer To The Brain 7/17/2017 10:20:07 AM
Voyager Therapeutics (VYGR) Announces Clinical Trial Update With VY-AADC01 For Advanced Parkinson’s Disease 6/26/2017 11:09:43 AM
Voyager Therapeutics (VYGR) Selects Lead Clinical Candidate For Huntington’s Disease 6/1/2017 11:02:13 AM
Voyager Therapeutics (VYGR) Reports First Quarter 2017 Financial Results And Corporate Highlights 5/10/2017 12:12:51 PM
Voyager Therapeutics (VYGR) Announces Additional Results From Phase Ib Trial Of VY-AADC01 For Advanced Parkinson’s Disease 4/25/2017 9:53:47 AM
Voyager Therapeutics (VYGR) To Host Fourth Quarter And Full Year 2016 Financial Results Conference Call 3/8/2017 8:21:04 AM
Voyager Therapeutics (VYGR) Appoints Jane Pritchett Henderson As Chief Financial Officer 1/3/2017 8:53:19 AM
MRI Interventions (MRIC)’ Clearpoint Neuro Navigation System Utilized In Voyager Therapeutics (VYGR)’ VY-AADC01 Phase Ib Trial; Positive Interim Results Reported 12/8/2016 7:18:28 AM
Voyager Therapeutics (VYGR) Soars as Parkinson’s Drug Shines in Early-Stage Trial 12/8/2016 5:48:18 AM
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals 8/23/2016 6:26:43 AM